INS and type 1 diabetes mellitus: Levels of baseline miRNAs related to microvascular complications in adults with type 1 diabetes did not differ by insulin delivery modality, but diverged during follow-up, with significant differences in the change in expression (between baseline and study end) in levels of 11 miRNAs (Table 1).